PU.1/Spi1 exacerbates ischemia-reperfusion induced acute kidney injury via upregulating Gata2 and promoting fibroblast activation

Kellum JA, Romagnani P, Ashuntantang G, Ronco C, Zarbock A, Anders HJ. Acute kidney injury. Nat Rev Dis Primers. 2021;7:52.

PubMed  Google Scholar 

Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet. 2012;380:756–66.

PubMed  Google Scholar 

Basile DP. The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. Kidney Int. 2007;72:151–6.

CAS  PubMed  Google Scholar 

Raup-Konsavage WM, Wang Y, Wang WW, Feliers D, Ruan H, Reeves WB. Neutrophil peptidyl arginine deiminase-4 has a pivotal role in ischemia/reperfusion-induced acute kidney injury. Kidney Int. 2018;93:365–74.

CAS  PubMed  Google Scholar 

de Oliveira RC, Wilson SE. Fibrocytes, wound healing, and corneal fibrosis. Invest Ophthalmol Vis Sci. 2020;61:28.

PubMed  PubMed Central  Google Scholar 

Talbott HE, Mascharak S, Griffin M, Wan DC, Longaker MT. Wound healing, fibroblast heterogeneity, and fibrosis. Cell Stem Cell. 2022;29:1161–80.

CAS  PubMed  PubMed Central  Google Scholar 

Lynch MD, Watt FM. Fibroblast heterogeneity: implications for human disease. J Clin Invest. 2018;128:26–35.

PubMed  PubMed Central  Google Scholar 

Tiggelman AMB, Boers W, Lintherst C, Brand HS, Sala M, Chamuleau RAF. Interleukin-6 production by human liver (myo)fibroblasts in culture - evidence for a regulatory role of lps, Il-1-beta and Tnf-alpha. J Hepatol. 1995;23:295–306.

CAS  PubMed  Google Scholar 

Travers JG, Kamal FA, Robbins J, Yutzey KE, Blaxall BC. Cardiac fibrosis: the fibroblast awakens. Circ Res. 2016;118:1021–40.

CAS  PubMed  PubMed Central  Google Scholar 

Aggarwal S, Wang ZX, Pacheco DRF, Rinaldi A, Rajewski A, Callemeyn J, et al. SOX9 switch links regeneration to fibrosis at the single-cell level in mammalian kidneys. Science. 2024;383:eadd6371.

CAS  PubMed  PubMed Central  Google Scholar 

Humphreys BD, Bonventre JV. Mesenchymal stem cells in acute kidney injury. Annu Rev Med. 2008;59:311–25.

CAS  PubMed  Google Scholar 

Zhou D, Fu H, Xiao L, Mo H, Zhuo H, Tian X, et al. Fibroblast-specific beta-catenin signaling dictates the outcome of AKI. J Am Soc Nephrol. 2018;29:1257–71.

CAS  PubMed  PubMed Central  Google Scholar 

Bendavid Y, Giddens EB, Letwin K, Bernstein A. Erythroleukemia induction by Friend murine leukemia-virus - insertional activation of a new member of the Ets gene family, Fli-1, closely linked to C-Ets-1. Gene Dev. 1991;5:908–18.

CAS  PubMed  Google Scholar 

Zhao XH, Bartholdy B, Yamamoto Y, Evans EK, Alberich-Jordà M, Staber PB, et al. PU.1-c-Jun interaction is crucial for PU.1 function in myeloid development. Commun Biol. 2022;5:961.

CAS  PubMed  PubMed Central  Google Scholar 

Li GL, Hao WK, Hu WX. Transcription factor PU.1 and immune cell differentiation (Review). Int J Mol Med. 2020;46:1943–50.

CAS  PubMed  Google Scholar 

Ralvenius WT, Andresen JL, Huston MM, Penney J, Bonner JM, Fenton OS, et al. Nanoparticle-mediated delivery of anti-PU.1 siRNA via localized intracisternal administration reduces neuroinflammation. Adv Mater. 2024;36:e2309225.

PubMed  Google Scholar 

Liu QM, Yu JJ, Wang LH, Tang YL, Zhou Q, Ji SH, et al. Inhibition of PU.1 ameliorates metabolic dysfunction and non-alcoholic steatohepatitis. J Hepatol. 2020;73:361–70.

CAS  PubMed  Google Scholar 

Wohlfahrt T, Rauber S, Uebe S, Luber M, Soare A, Ekici A, et al. PU.1 controls fibroblast polarization and tissue fibrosis. Nature. 2019;566:344.

CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y, Tang PM, Niu Y, Garcia Cordoba CA, Huang XR, Yu C, et al. Long non-coding RNA LRNA9884 promotes acute kidney injury via regulating NF-κB-mediated transcriptional activation of MIF. Front Physiol. 2020;11:590027.

PubMed  PubMed Central  Google Scholar 

Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 2012;81:442–8.

PubMed  Google Scholar 

Xue JL, Daniels F, Star RA, Kimmel PL, Eggers PW, Molitoris BA, et al. Incidence and mortality of acute renal failure in medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol. 2006;17:1135–42.

PubMed  Google Scholar 

Venkatachalam MA, Weinberg JM, Kriz W, Bidani AK. Failed tubule recovery, AKI-CKD transition, and kidney disease progression. J Am Soc Nephrol. 2015;26:1765–76.

CAS  PubMed  PubMed Central  Google Scholar 

Maremonti F, Meyer C, Linkermann A. Mechanisms and models of kidney tubular necrosis and nephron loss. J Am Soc Nephrol. 2022;33:472–86.

CAS  PubMed  PubMed Central  Google Scholar 

Zuk A, Bonventre JV. Acute kidney injury. Annu Rev Med. 2016;67:293–307.

CAS  PubMed  PubMed Central  Google Scholar 

Leaf DE, Rajapurkar M, Lele SS, Mukhopadhyay B, Boerger EAS, Mc Causland FR, et al. Iron, hepcidin, and death in human AKI. J Am Soc Nephrol. 2019;30:493–504.

CAS  PubMed  PubMed Central  Google Scholar 

Li X, Yuan F, Xiong Y, Tang Y, Li Z, Ai J, et al. FAM3A plays a key role in protecting against tubular cell pyroptosis and acute kidney injury. Redox Biol. 2024;74:103225.

CAS  PubMed  PubMed Central  Google Scholar 

Lin QS, Li S, Jiang N, Jin HJ, Shao XH, Zhu XY, et al. Inhibiting NLRP3 inflammasome attenuates apoptosis in contrast-induced acute kidney injury through the upregulation of HIF1A and BNIP3-mediated mitophagy. Autophagy. 2021;17:2975–90.

CAS  PubMed  Google Scholar 

Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med. 2012;18:1028–40.

CAS  PubMed  PubMed Central  Google Scholar 

Sakai N, Wada T, Yokoyama H, Lipp M, Ueha S, Matsushima K, et al. Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc Natl Acad Sci USA. 2006;103:14098–103.

CAS  PubMed  PubMed Central  Google Scholar 

Baues M, Dasgupta A, Ehling J, Prakash J, Boor P, Tacke F, et al. Fibrosis imaging: current concepts and future directions. Adv Drug Deliv Rev. 2017;121:9–26.

CAS  PubMed  PubMed Central  Google Scholar 

Kinchen J, Chen HH, Parikh K, Antanaviciute A, Jagielowicz M, Fawkner-Corbett D, et al. Structural remodeling of the human colonic mesenchyme in inflammatory bowel disease. Cell. 2018;175:372–86.e17.

CAS  PubMed  PubMed Central  Google Scholar 

West NR, Hegazy AN, Owens BMJ, Bullers SJ, Linggi B, Buonocore S, et al. Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease. Nat Med. 2017;23:579–89.

CAS  PubMed  PubMed Central  Google Scholar 

Huang B, Chen Z, Geng L, Wang J, Liang H, Cao Y, et al. Mucosal profiling of pediatric-onset colitis and IBD reveals common pathogenics and therapeutic pathways. Cell. 2019;179:1160–76.e24.

CAS  PubMed  Google Scholar 

Komatsu N, Takayanagi H. Mechanisms of joint destruction in rheumatoid arthritis - immune cell-fibroblast-bone interactions. Nat Rev Rheumatol. 2022;18:415–29.

CAS  PubMed  Google Scholar 

Zhang Y, Huang H, Kong Y, Xu C, Dai L, Geng X, et al. Kidney tubular transcription co-activator, Yes-associated protein 1 (YAP), controls the expression of collecting duct aquaporins and water homeostasis. Kidney Int. 2023;103:501–13.

CAS  PubMed  Google Scholar 

Estrela GR, Freitas-Lima LC, Budu A, Arruda AC, Perilhao MS, Fock RA, et al. Chronic kidney disease induced by cisplatin, folic acid and renal ischemia reperfusion induces anemia and promotes GATA-2 activation in mice. Biomedicines. 2021;9:769.

CAS  PubMed  PubMed Central 

Comments (0)

No login
gif